Microbix Biosystems Inc. (TSE:MBX) Director Cameron Lionel Groome Sells 200,000 Shares

Microbix Biosystems Inc. (TSE:MBX) Director Cameron Lionel Groome sold 200,000 shares of Microbix Biosystems stock in a transaction that occurred on Wednesday, January 22nd. The stock was sold at an average price of C$0.43, for a total value of C$86,500.00.

Microbix Biosystems Trading Down 3.8 %

Shares of MBX stock opened at C$0.50 on Friday. Microbix Biosystems Inc. has a fifty-two week low of C$0.29 and a fifty-two week high of C$0.52. The company has a debt-to-equity ratio of 22.68, a quick ratio of 5.57 and a current ratio of 6.62. The stock’s fifty day moving average is C$0.38 and its two-hundred day moving average is C$0.35. The firm has a market capitalization of C$68.35 million, a P/E ratio of 12.50 and a beta of 0.34.

About Microbix Biosystems

Microbix Biosystems Inc, a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products.